Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish RegionsReport as inadecuate




Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions - Download this document for free, or read online. Document in PDF available to download.

Clinical and Translational Oncology

, Volume 19, Issue 3, pp 341–356

First Online: 25 August 2016Received: 11 May 2016Accepted: 21 July 2016DOI: 10.1007-s12094-016-1535-8

Cite this article as: Salvador, J., Urtasun, J.A., Duart, F.J.B. et al. Clin Transl Oncol 2017 19: 341. doi:10.1007-s12094-016-1535-8

Abstract

PurposeThe Spanish Society of Medical Oncology SEOM has conducted a study on the access to oncologic drugs across the 17 Spanish Regions with the aim of identifying potential heterogeneities and making proposals for eliminating the barriers identified at the different levels.

MethodsAn Expert Panel made up of medical oncologists designed a survey on certain indications approved for 11 drugs in the approach of breast cancer, melanoma, lung cancer, prostate cancer and support treatment. This survey was sent to 144 National Health System NHS hospitals.

Results77 hospitals answered the survey. The information modules analysed were: scope of the Commission that establishes binding decisions related to drug access; conditions, stages and periods of drug application, approval and administration processes; barriers to accessing drugs.

ConclusionsThe study shows variability in drug access. The SEOM makes proposals addressed to reducing the differences identified and homogenizing drug access conditions.

KeywordsAntineoplastic agents Heterogeneity Barriers Inequities Spain An erratum to this article is available at http:-dx.doi.org-10.1007-s12094-017-1628-z.

Download fulltext PDF



Author:

Source: https://link.springer.com/



DOWNLOAD PDF




Related documents